Human epidermal growth factor receptor 2 (HER2) is a growth factor receptor gene that is amplified in approximately 15–20% of breast cancers, and HER2 protein overexpression on the plasma membrane of tumor cells reportedly correlates with a poor prognosis [1–6]. Here, ERBB2 is linked to breast carcinoma.